Clinical Trial Update: Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

View source ↗

Summary

This clinical trial update evaluated whether gabapentin affects the risk of pancreatic and renal cancers; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Renal Cell Carcinoma
• Renal Pelvis Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Renal Pelvis Cancer, Restless Legs Syndrome | Status: COMPLETED | Results posted: 2011-01-07